Loading…
Legislative Progress
Introduced
February 26, 2015
Latest Action
February 26, 2015
Primary Sponsor
Richard J. DurbinDemocratic(IL)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,548 other S bills in the 114th — cohort avg 43d
Detergent Poisoning And Child Safety Act of 2015 or the Detergent PACS Act of 2015 Requires the Consumer Product Safety Commission (CPSC) to establish safety standards for liquid detergent packets to protect children who are younger than five years of age from injury or illness. Directs the CPSC to establish such standards by promulgating a rule or adopting voluntary ASTM International standards. Provides for any final rule that is promulgated to include: (1) requirements for special packaging and warning labels, (2) standards to make the color and design of packets less attractive to children, and (3) liquid composition standards to make the consequences of exposure less severe. Requires the rule or standards to be treated as consumer product safety standards under the Consumer Product Safety Act.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (13)
Read twice and referred to the Committee on Commerce, Science, and Transportation. (text of measure as introduced: CR S1164-1165)
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2016 · second_quarter · Consumer Issues/Safety/Products
Consumer Product Safety Issues HR 1139/S. 588, Detergent Poisoning & Child Safety Act of 2015
Client expense: Not reported · Firm income: $10,000
Government targets: SENATE
2016 · fourth_quarter · Health Issues
H.R. 1270, Restoring Access to Medication Act of 2015, all provisions S. 709, Restoring Access to Medication Act of 2015, all provisions H.R. 5395, Expanding Capacity for Health Outcomes (ECHO) Act, all provisions S. 2873, Expanding Capacity for Health Outcomes (ECHO) Act, all provisions H.R. 6, 21st Century Cures Act, all provisions H.R. 34, 21st Century Cures Act, all provisions H.R. 293, To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes, all provisions S.2978, Protect Continuing Physician Education and Patient Care Act, all provisions H.R. 1877, Mental Health First Aid Act of 2016, all provisions H.R. 4365, Protecting Patient Access to Emergency Medications Act of 2016, all provisions H.R. 1217, Public Safety and Second Amendment Rights Protection Act of 2015, all provisions H.R.1192, National Clinical Care Commission Act, all provisions S. 586, National Clinical Care Commission Act, all provisions H.R. 1725, National All Schedules Prescription Electronic Reporting Reauthorization (NASPER) Act of 2015, all provisions S.480, National All Schedules Prescription Electronic Reporting Reauthorization (NASPER) Act of 2016, all provisions H.R.2536, Recovery Enhancement for Addiction Treatment (TREAT) Act, all provisions S. 1455, Recovery Enhancement for Addiction Treatment (TREAT) Act, all provisions S. 524, Comprehensive Addiction and Recovery Act (CARA) of 2016, all provisions S. 3077, Marijuana Effective Drug Studies (MEDS) Act of 2016, all provisions H.R. 1139, Detergent Poisoning And Child Safety Act of 2015, all provisions S. 588, Detergent Poisoning And Child Safety Act of 2015, all provisions H.R. 5926, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017, language relating to non-burning sunshine H.R.1217, Public Safety and Second Amendment Rights Protection Act of 2015, all provisions Health Savings Accounts - Prescription requirements for over-the-counter medications Telemedicine - Interstate Medical Licensure Compact Health Care Reform Sunshine Act Surprise Medical Billing Rep. Tom Price nomination for HHS Secretary Health Data Security Gun Violence TRUST IT EHR Interoperability Meaningful Use 21st Century Cures, Innovations Diabetes Zika funding FDA's blood donor deferral recommendations Nootropics or "Smart Drugs" At-risk children/elevated blood lead level early-intervention screening programs Race/ethnicity data collection standards Opioid epidemic National Practitioner Data Bank Laboratory developed tests Precision medicine Compounding Health Insurance Portability and Accountability Act (HIPAA) FDA - Physician practice issues FDA - Device innovation Telehealth - payment
Client expense: $3,990,000 · Firm income: Not reported
2016 · fourth_quarter · Medicare/Medicaid
Affordable Care Act - Monitored ongoing discussions about potential changes to the Affordable Care Act. Raised concerns about potential to repeal the law without a concurrent replacement plan that offers similar coverage levels, and provides appropriate Medicare and Medicaid reimbursement for hospitals. 21st Century Cures Act (H.R. 6, H.R. 34) - Supported passage of the 21st Century Cures Act - shared concerns regarding changes to Medicare reimbursement for Home Infusion Treatments. Hospital outpatient department reimbursement (H.R. 34, H.R. 5273 - The Helping Hospitals Improve Patient Care Act) - Supported passage in the House of H.R. 5273 and inclusion of key provisions in the 21st Century Cures Act The Establishing Beneficiary Equity in the Hospital Readmission Program (H.R. 1343, S. 588, H.R. 34) - Supported passage of legislation that would incorporate socioeconomic conditions into penalty calculations under the hospital readmissions reduction program. Supported inclusion in 21st Century Cures Act. Medicare Innovations Center Mandatory Demonstration projects - Monitored Congressional activity related to proposed mandatory demonstration projects under the Center for Medicare and Medicaid Innovations (Medicare Part B Drug Demo, Comprehensive Care for Joint Replacement, Episode Payment Model bundles). Mental Health Reform efforts - (H.R. 2646, S. 2151, H.R. 34) - Tracked ongoing discussions around reforming the mental health system in our country. Supported inclusion of provisions to allow for Medicaid funding for use in lengthier inpatient treatment options.
Client expense: $125,000 · Firm income: Not reported
2016 · fourth_quarter · Consumer Issues/Safety/Products
FDA Reform - Modernization of Cosmetic Regulations S. 1014 - Personal Care Products Safety Act Safe Cosmetics Modernization Act, H.R. 4075 Safety of Cosmetic/Personal Care/Household Cleaning Products & Ingredients FDA Regulation of OTC Drugs Ingredient Communication H.R. 1321/S. 1424 - Microbead-Free Waters Act of 2015 H.R. 1139/S. 588 - Detergent PACS Act of 2015 H.R. 5205 - Cleaning Product Right to Know Act
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
2016 · fourth_quarter · Consumer Issues/Safety/Products
FDA regulation of cosmetics. Consumer product safety issues. H.R. 1139 and S. 588, Detergent PACS Act of 2015. H.R. 3250, DXM Abuse Prevention Act of 2015.
Client expense: Not reported · Firm income: $50,000
| Democratic |
| MA |
| Richard Blumenthal | Democratic | CT |
| Tom Udall | Democratic | NM |
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Consumer Issues/Safety/Products
FDA regulation of antimicrobial hand soaps H.R.1139/S.588, Detergent PACS Act of 2015, Monitor regulation of single use laundry detergent packets.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES
2016 · fourth_quarter · Taxation/Internal Revenue Code
H.R. 160, S. 149, S. 588 bills related to the Medical Device Excise Tax Issues related to the reform of the tax code
Client expense: $650,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Consumer Issues/Safety/Products
- Consumer Product Safety Issues - HR 1139 / S.588, Detergent Poisoning & Child Safety Act of 2015
Client expense: $779,741 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)
2016 · fourth_quarter · Manufacturing
Lobbying related to consumer product safety and S.588 the Detergent Poisoning And Child Safety Act of 2015.
Client expense: Not reported · Firm income: $50,000
Government targets: SENATE
2016 · fourth_quarter · Consumer Issues/Safety/Products
S. 588 and H.R. 1139 'Detergent PACS Act of 2015' consumer product safety matters
Client expense: $96,000 · Firm income: Not reported
Government targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Consumer Issues/Safety/Products
- Consumer Product Safety Issues - HR 1139 / S.588, Detergent Poisoning & Child Safety Act of 2015
Client expense: $721,244 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)
2016 · third_quarter · Taxation/Internal Revenue Code
H.R. 160, S. 149, S. 588 bills related to the Medical Device Excise Tax Issues related to the reform of the tax code
Client expense: $700,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Consumer Issues/Safety/Products
FDA Reform - Modernization of Cosmetic Regulations S. 1014 - Personal Care Products Safety Act Safe Cosmetics Modernization Act, H.R. 4075 Safety of Cosmetic/Personal Care/Household Cleaning Products & Ingredients FDA Regulation of OTC Drugs Ingredient Communication H.R. 1321/S. 1424 - Microbead-Free Waters Act of 2015 H.R. 1139/S. 588 - Detergent PACS Act of 2015 H.R. 5205 - Cleaning Product Right to Know Act
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Consumer Issues/Safety/Products
FDA regulation of cosmetics. Consumer product safety issues. H.R. 1139 and S. 588, Detergent PACS Act of 2015. H.R. 3250, DXM Abuse Prevention Act of 2015. S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Consumer Issues/Safety/Products
H.R.1139/S.588, Detergent PACS Act of 2015, Monitor regulation of single use laundry detergent packets.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Medicare/Medicaid
Hospital outpatient department reimbursement (H.R. 5273 - The Helping Hospitals Improve Patient Care Act) - Supported passage in the House of HR 5273. Urged Senate activity on similar legislation to allow under-construction and other hospital-affiliated outpatient departments impacted by the 2015 Debt Ceiling and Budget Agreement to be grandfathered in under previous outpatient reimbursement rules, make modifications to the Medicare hospital readmissions reduction program, and other changes. Advocated for CMS to be flexible in implementation of the new law. The Establishing Beneficiary Equity in the Hospital Readmission Program (H.R. 1343, S. 588) - Supported passage of legislation that would incorporate sociodemographic conditions into penalty calculations under the hospital readmissions reduction program. Medicare Total Quality Hospital Star Ratings (H.R. 5297 - The Hospital Quality Rating Transparency Act) - Advocated for a delay in the release of the new star ratings until the changes were made to the proposed methodology. Medicare Innovations Center Mandatory Demonstration projects - Monitored Congressional activity related to proposed mandatory demonstration projects under the Center for Medicare and Medicaid Innovations (Medicare Part B Drug Demo, Comprehensive Care for Joint Replacement, Cardiac Payment Bundles). Tracked Congressional activity to limit or prevent CMS from moving forward with such demonstrations. Mental Health Reform efforts - (H.R. 2646, S. 2151) - Tracked ongoing discussions around reforming the mental health system in our country. Supported inclusion of provisions to allow for Medicaid funding for use in lengthier inpatient treatment options.
Client expense: $130,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Consumer Issues/Safety/Products
S. 588 and H.R. 1139 'Detergent PACS Act of 2015' consumer product safety matters
Client expense: $83,000 · Firm income: Not reported
Government targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Consumer Issues/Safety/Products
Detergent PACS Act of 2015 (S. 588); STURDY Act (H.R. 5442); Pink Tax Repeal Act
Client expense: $30,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Consumer Issues/Safety/Products
- Consumer Product Safety Issues - HR 1139 / S.588, Detergent Poisoning & Child Safety Act of 2015
Client expense: $783,084 · Firm income: Not reported
Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)
2016 · second_quarter · Taxation/Internal Revenue Code
H.R. 160, S. 149, S. 588 bills related to the Medical Device Excise Tax Issues related to the reform of the tax code
Client expense: $680,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Consumer Issues/Safety/Products
FDA regulation of cosmetics. Consumer product safety issues. H.R. 1139 and S. 588, Detergent PACS Act of 2015. H.R. 3250, DXM Abuse Prevention Act of 2015. S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Medicare/Medicaid
Hospital outpatient department reimbursement (H.R. 5273 - The Helping Hospitals Improve Patient Care Act) - Supported passage of legislation to allow under-construction and other hospital-affiliated outpatient departments impacted by the 2015 Debt Ceiling and Budget Agreement to be grandfathered in under previous outpatient reimbursement rules, make modifications to the Medicare hospital readmissions reduction program, and other changes. The Establishing Beneficiary Equity in the Hospital Readmission Program (H.R. 1343, S. 588) - Supported passage of legislation that would incorporate sociodemographic conditions into penalty calculations under the hospital readmissions reduction program. Hospital site-neutral payment policies - monitored discussions of proposals that would reduce reimbursement for services delivered in a hospital setting. Medicare Total Quality Hospital Star Ratings - Advocated for a delay in the release of the new star ratings until the changes were made to the proposed methodology. Medicare Part B Drug Demonstration - Monitored the proposed demonstration and the impact it may have on hospitals. Tracked Congressional activity reviewing the proposal and legislation (H.R. 5122) to prevent CMS from moving forward with the demonstration.
Client expense: $130,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Consumer Issues/Safety/Products
FDA Reform - Modernization of Cosmetic Regulations S. 1014 - Personal Care Products Safety Act Safe Cosmetics Modernization Act, H.R. 4075 Safety of Cosmetic/Personal Care/Household Cleaning Products & Ingredients FDA Regulation of OTC Drugs Ingredient Communication H.R. 1321/S. 1424 - Microbead-Free Waters Act of 2015 H.R. 1139/S. 588 - Detergent PACS Act of 2015 H.R. 5205 - Cleaning Product Right to Know Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Consumer Issues/Safety/Products
H.R.1139/S.588, Detergent PACS Act of 2015, Regulation of single use laundry detergent packets.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Consumer Issues/Safety/Products
S. 588 and H.R. 1139 'Detergent PACS Act of 2015' consumer product safety matters
Client expense: $135,000 · Firm income: Not reported
Government targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Consumer Issues/Safety/Products
Consumer Product Safety Issues HR 1139/S. 588, Detergent Poisoning & Child Safety Act of 2015
Client expense: Not reported · Firm income: Not reported
2016 · first_quarter · Taxation/Internal Revenue Code
H.R. 160, S. 149, S. 588 bills related to the Medical Device Excise Tax Issues related to the reform of the tax code
Client expense: $1,140,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · first_quarter · Consumer Issues/Safety/Products
- Consumer Product Safety Issues - HR 1139 / S.588, Detergent Poisoning & Child Safety Act of 2015
Client expense: $925,001 · Firm income: Not reported
Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)
2016 · first_quarter · Medicare/Medicaid
Hospital outpatient department reimbursement - Advocated for legislation to allow under-construction and other hospital-affiliated outpatient departments impacted by the 2015 Debt Ceiling and Budget Agreement (H.R. 1314)to be grandfathered in under previous outpatient reimbursement rules. Hospital site-neutral payment policies - monitored discussions of proposals that would reduce reimbursement in hospital settings. The Establishing Beneficiary Equity in the Hospital Readmission Program (H.R. 1343, S. 588) - Supported passage of legislation that would incorporate sociodemographic conditions into penalty calculations under the hospital readmissions reduction program. Ways and Means Committee hospital legislation (H.R. 3291, H.R. 3292, H.R. 3288) - Monitored activity of three bills and ongoing discussions in the House Ways and Means Committee that could impact hospitals through changes to coding, indirect medical education reimbursement and updates to disproportionate share hospital program funding.
Client expense: $110,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2016 · first_quarter · Consumer Issues/Safety/Products
FDA Reform - Modernization of Cosmetic Regulations S. 1014 - Personal Care Products Safety Act Safe Cosmetics Modernization Act, H.R. 4075 Safety of Cosmetic/Personal Care/Household Cleaning Products & Ingredients FDA Regulation of OTC Drugs Ingredient Communication H.R. 1321/S. 1424 - Microbead-Free Waters Act of 2015 H.R. 1139/S. 588 - Detergent PACS Act of 2015
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · first_quarter · Consumer Issues/Safety/Products
H.R.1139/S.588, Detergent PACS Act of 2015, Regulation of single use laundry detergent packets.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · first_quarter · Consumer Issues/Safety/Products
S. 588 and H.R. 1139 'Detergent PACS Act of 2015' consumer product safety matters
Client expense: $103,000 · Firm income: Not reported
Government targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
2016 · first_quarter · Consumer Issues/Safety/Products
FDA regulation of cosmetics. Consumer product safety issues. H.R. 1139 and S. 588, Detergent PACS Act of 2015. H.R. 3250, DXM Abuse Prevention Act of 2015. S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · fourth_quarter · Medicare/Medicaid
Debt Ceiling and Budget Agreement (H.R. 1314) - Opposed inclusion of provisions that extend Medicare sequestration and expressed opposition to a provision that reduces Medicare reimbursement for new off-campus hospital outpatient departments. Consolidated Appropriations Act (H.R. 2029) - Advocated for inclusion of provisions in year-end funding legislation that would allow under-construction hospital-affiliated outpatient departments to be grandfathered in under previous outpatient reimbursement rules. The Establishing Beneficiary Equity in the Hospital Readmission Program (H.R. 1343, S. 588) - Supported passage of legislation that would incorporate sociodemographic conditions into penalty calculations under the hospital readmissions reduction program. Senate Finance Committee Chronic Care options - Monitored development of Senate Finance Committee's policy options for treating patients with chronic conditions. Ways and Means Committee hospital legislation (H.R. 3291, H.R. 3292, H.R. 3288) - Monitored activity of three bills in the House Ways and Means Committee that could impact hospitals through changes to coding, indirect medical education reimbursement and updates to disproportionate share hospital program funding.
Client expense: $105,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2015 · fourth_quarter · Taxation/Internal Revenue Code
H.R. 160, S. 149, S. 588 bills related to the Medical Device Excise Tax HR 636, S.341, S. 537 and other bills related to small business tax priorities Issues related to the reform of the tax code
Client expense: $980,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · fourth_quarter · Consumer Issues/Safety/Products
- Consumer Product Safety Issues - HR 1139 / S.588, Detergent Poisoning & Child Safety Act of 2015
Client expense: $1,190,507 · Firm income: Not reported
Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)
2015 · fourth_quarter · Consumer Issues/Safety/Products
FDA regulation of cosmetics. Consumer product safety issues. H.R. 1139 and S. 588, Detergent PACS Act of 2015. H.R. 1321 and S. 1424, Microbead-Free Waters Act of 2015. H.R. 3250, DXM Abuse Prevention Act of 2015. S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · fourth_quarter · Taxation/Internal Revenue Code
H.R. 160, S. 149, S. 588 bills related to the Medical Device Excise Tax HR 636, S.341, S. 537 and other bills related to small business tax priorities Issues related to the reform of the tax code
Client expense: $910,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · fourth_quarter · Health Issues
Right Start Child Care and Education Act (S.446) Child Nicotine Poisoning Prevention Act of 2015 (S. 142 and H.R. 1375) Child and Dependent Care FSA Enhancement Act (S. 215 H.R. 1720) Home Visiting Extension Act of 2015 (H.R. 1372) Detergent PACS Act of 2015 (S. 588 and H.R. 1139) Child Nicotine Poisoning Prevention Act of 2015 (S.142) Child Nicotine Poisoning Prevention Act of 2015 (H.R. 1375)
Client expense: $10,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · fourth_quarter · Consumer Issues/Safety/Products
FDA Reform - Modernization of Cosmetic Regulations S. 1014 - Personal Care Products Safety Act Safety of Cosmetic/Personal Care/Household Cleaning Products & Ingredients FDA Regulation of OTC Drugs Ingredient Communication H.R. 1321/S. 1424 - Microbead-Free Waters Act of 2015 H.R. 1139/S. 588 - Detergent PACS Act of 2015
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · fourth_quarter · Consumer Issues/Safety/Products
H.R.1139/S.588, Detergent PACS Act of 2015, Monitor regulation of single use laundry detergent packets.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · fourth_quarter · Consumer Issues/Safety/Products
S.588/H.R. 1139 - Detergent PACS Act of 2015.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · fourth_quarter · Consumer Issues/Safety/Products
S. 588 and H.R. 1139 'Detergent PACS Act of 2015' consumer product safety matters
Client expense: $102,000 · Firm income: Not reported
Government targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
2015 · third_quarter · Consumer Issues/Safety/Products
- Consumer Product Safety Issues - HR 1139 / S.588, Detergent Poisoning & Child Safety Act of 2015
Client expense: $1,031,307 · Firm income: Not reported
Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)
2015 · third_quarter · Consumer Issues/Safety/Products
FDA regulation of cosmetics. Consumer product safety issues. H.R. 1139 and S. 588, Detergent PACS Act of 2015. H.R. 1321 and S. 1424, Microbead-Free Waters Act of 2015. H.R. 3250, DXM Abuse Prevention Act of 2015. S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · third_quarter · Consumer Issues/Safety/Products
FDA Reform - Modernization of Cosmetic Regulations S. 1014 - Personal Care Products Safety Act Safety of Cosmetic/Personal Care/Household Cleaning Products & Ingredients FDA Regulation of OTC Drugs Ingredient Communication H.R. 1321/S. 1424 - Microbead-Free Waters Act of 2015 H.R. 1139/S. 588 - Detergent PACS Act of 2015
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · third_quarter · Taxation/Internal Revenue Code
H.R. 160, S. 149, S. 588 bills related to the Medical Device Excise Tax HR 636, S.341, S. 537 and other bills related to small business tax priorities Issues related to the reform of the tax code
Client expense: $480,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · third_quarter · Budget/Appropriations
Detergent PACS Act of 2015 (S. 588 and H.R. 1139) Ensuring Access to Clinical Trials Act of 2015 (S.139) H.R. 710 - Continuing Appropriations Act S. 1695 - U.S. Senate FY 2016 Labor, HHS Appropriations Act Continuing Appropriations Act, 2016 (H.R. 719) H.R. 3020 - House of Representatives FY 2016 Labor, HHS Appropriations Act
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · third_quarter · Consumer Issues/Safety/Products
H.R.1139/S.588, Detergent PACS Act of 2015, Regulation of single use laundry detergent packets.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · third_quarter · Medicare/Medicaid
Medicare and Medicaid EHR incentive program meaningful use rules - urged CMS to release the final rules to provide flexibility for eligible hospitals and providers for 2015. Advocated that CMS consider delaying final meaningful use stage 3 rules until greater interoperability is achieved. The Establishing Beneficiary Equity in the Hospital Readmission Program (H.R. 1343, S. 588) - supported passage of legislation that would incorporate sociodemographic conditions into penalty calculations under the hospital readmissions reduction program. Comprehensive Care for Joint Replacement program - Tracked release of proposal to require mandatory payment bundling for hip and knee replacements in selected geographic regions across the country. Expressed concern about mandatory nature of the program and urged needed regulatory flexibility for hospitals. Ways and Means Committee hospital legislation (H.R. 3291, H.R. 3292, H.R. 3288) - monitored release of three bills in the House Ways and Means Committee that would impact hospitals through changes to coding, indirect medical education reimbursement and updates to disproportionate share hospital program funding. Hospital Two-midnight rule - advocated for extending enforcement delay on two-midnight rule to align timing with proposed regulatory delay through the end of 2015.
Client expense: $110,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE